As common clinical indicators for predicting sepsis, both HBP and D-dimer have high diagnostic effectiveness. Furthermore, the combined application of these two biomarkers can achieve favorable effects.

In clinical practice, the combined application of these two biomarkers with the SOFA score and other indicators can predict the 28-day mortality and monitor the curative effect of treatment on patients with severe sepsis.

Also, dynamic monitoring of HBP and D-dimer can quickly determine the prognosis and predict the treatment effect.

These findings can be applied in clinical treatment, allowing clinicians to comprehensively evaluate the condition of patients and promptly improve therapeutic regimens, thereby improving the prognosis of patients with sepsis.

Read More